Epigenetic changes and suppression of the nuclear factor of activated T cell 1 (NFATC1) promoter in human lymphomas with defects in immunoreceptor signaling

American Journal of Pathology

Volumn 172, Issue 1, 2008, Pages 215-224

  Akimzhanov, Askar ^a   Krenacs, Laszlo ^b   Schlegel, Timm ^a   Klein Hessling, Stefan ^a   Bagdi, Enikö ^b   Stelkovics, Eva ^b   Kondo, Eisaku ^c   Chuvpilo, Sergei ^a   Wilke, Philipp ^a   Avots, Andris ^a   Gattenlöhner, Stefan ^a   Müller Hermelink, Hans Konrad ^a   Palmetshofer, Alois ^a   Serfling, Edgar ^a,d  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b BAY ZOLTÁN NONPROFIT LTD FOR APPLIED RESEARCH   (Hungary)

^c OKAYAMA UNIVERSITY   (Japan)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE; NUCLEAR FACTOR; NUCLEAR PROTEIN; TRANSCRIPTION FACTOR SP1;

ACETYLATION; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CPG ISLAND; DNA BINDING; GENE; GENE SILENCING; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOMA; METHYLATION; NFATC1 GENE; NFATC2 GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 38749141374     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070294     Document Type: Article

References (55)

1. Serfling E, Berberich-Siebelt F, Chuvpilo S, Jankevics E, Klein-Hessling S, Twardzik T, Avots A: The role of NF-AT transcription factors in T cell activation and differentiation. Biochim Biophys Acta 2000, 1498:1-18
2. Hogan PG, Chen L, Nardone J, Rao A: Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003, 17:2205-2232
3. Macian F: NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 2005, 5:472-484
4. Baksh S, Widlund HR, Frazer-Abel AA, Du J, Fosmire S, Fisher DE, DeCaprio JA, Modiano JF, Burakoff SJ: NFATc2-mediated repression of cyclin-dependent kinase 4 expression. Mol Cell 2002, 10:1071-1081
5. Latinis KM, Norian LA, Eliason SL, Koretzky GA: Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells. J Biol Chem 1997, 272:31427-31434
6. Xiao S, Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Widom RL, Ju ST: FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Eur J Immunol 1999, 29:3456-3465
7. Li-Weber M, Laur O, Krammer PH: Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Eur J Immunol 1999, 29:3017-3027
8. Lee MO, Kang HJ, Kim YM, Oum JH, Park J: Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Eur J Biochem 2002, 269:1162-1170
9. Rengarajan J, Mittelstadt PR, Mages HW, Gerth AJ, Kroczek RA, Ashwell JD, Glimcher LH: Sequential involvement of NFAT and Egr transcription factors in FasL regulation. Immunity 2000, 12:293-300
10. Viola JP, Carvalho LD, Fonseca BP, Teixeira LK: NFAT transcription factors: from cell cycle to tumor development. Braz J Med Biol Res 2005, 38:335-344
11. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG: RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 2004, 32:D523-D527
12. Serfling E, Chuvpilo S, Liu J, Hofer T, Palmetshofer A: NFATc1 autoregulation: a crucial step for cell-fate determination. Trends Immunol 2006, 27:461-469
13. Glud SZ, Sorensen AB, Andrulis M, Wang B, Kondo E, Jessen R, Krenacs L, Stelkovics E, Wabl M, Serfling E, Palmetshofer A, Pedersen FS: A tumor-suppressor function for NFATc3 in T-cell lymphomagenesis by murine leukemia virus. Blood 2005, 106:3546-3552
14. Ranger AM, Gerstenfeld LC, Wang J, Kon T, Bae H, Gravallese EM, Glimcher MJ, Glimcher LH: The nuclear factor of activated T cells (NFAT) transcription factor NFATp (NFATc2) is a repressor of chondrogenesis. J Exp Med 2000, 191:9-22
15. Neal JW, Clipstone NA: A constitutively active NFATc1 mutant induces a transformed phenotype in 3T3-L1 fibroblasts. J Biol Chem 2003, 278:17246-17254
16. Marafioti T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TF, Du MQ, Leoncini L, Moller P, Natkunam Y, Siebert R, Mason DY: The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol 2005, 128:333-342
17. Pham LV, Tamayo AT, Yoshimura LC, Lin-Lee YC, Ford RJ: Constitutive NF-kappaB and NFAT activation in aggressive B-cell lymphomas synergistically activates the CD154 gene and maintains lymphoma cell survival. Blood 2005, 106:3940-3947
18. Kawano S, Otsu K, Kuruma A, Shoji S, Yanagida E, Muto Y, Yoshikawa F, Hirayama Y, Mikoshiba K, Furuichi T: ATP autocrine/ paracrine signaling induces calcium oscillations and NFAT activation in human mesenchymal stem cells. Cell Calcium 2006, 39:313-324
19. Buchholz M, Schatz A, Wagner M, Michl P, Linhart T, Adler G, Gress TM, Ellenrieder V: Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J 2006, 25:3714-3724
20. Medyouf H, Alcalde H, Berthier C, Guillemin MC, Dos Santos NR, Janin A, Decaudin D, de The H, Ghysdael J: Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 2007, 13:736-741
21. Jauliac S, Lopez-Rodriguez C, Shaw LM, Brown LF, Rao A, Toker A: The role of NFAT transcription factors in integrin-mediated carcinoma invasion. Nat Cell Biol 2002, 4:540-544
22. Yiu GK, Toker A: NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J Biol Chem 2006, 281:12210-12217
23. Yoeli-Lerner M, Yiu GK, Rabinovitz I, Erhardt P, Jauliac S, Toker A: Akt blocks breast cancer cell motility and invasion through the transcription factor NFAT. Mol Cell 2005, 20:539-550
24. Patra AK, Na SY, Bommhardt U: Active protein kinase B regulates TCR responsiveness by modulating cytoplasmic-nuclear localization of NFAT and NF-kappa B proteins. J Immunol 2004, 172:4812-4820
25. Patra AK, Drewes T, Engelmann S, Chuvpilo S, Kishi H, Hunig T, Serfling E, Bommhardt UH: PKB rescues calcineurin/NFAT-induced arrest of Rag expression and pre-T cell differentiation. J Immunol 2006, 177:4567-4576
26. Bonzheim I, Geissinger E, Roth S, Zettl A, Marx A, Rosenwald A, Muller-Hermelink HK, Rudiger T: Anaplastic large cell lymphomas lack the expression of T-cell receptor molecules or molecules of proximal T-cell receptor signaling. Blood 2004, 104:3358-3360
27. Schwering I, Brauninger A, Klein U, Jungnickel B, Tinguely M, Diehl V, Hansmann ML, Dalla-Favera R, Rajewsky K, Kuppers R: Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma. Blood 2003, 101:1505-1512
28. Marafioti T, Pozzobon M, Hansmann ML, Gaulard P, Barth TF, Copie-Bergman C, Roberton H, Ventura R, Martin-Subero JI, Gascoyne RD, Pileri SA, Siebert R, Hsi ED, Natkunam Y, Moller P, Mason DY: Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma. Leukemia 2005, 19:856-861
29. Chuvpilo S, Jankevics E, Tyrsin D, Akimzhanov A, Moroz D, Jha MK, Schulze-Luehrmann J, Santner-Nanan B, Feoktistova E, Konig T, Avots A, Schmitt E, Berberich-Siebelt F, Schimpl A, Serfling E: Autoregulation of NFATc1/A expression facilitates effector T cells to escape from rapid apoptosis. Immunity 2002, 16:881-895
30. Northrop JP, Ho SN, Chen L, Thomas DJ, Timmerman LA, Nolan GP, Admon A, Crabtree GR: NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 1994, 369:497-502
31. Chuvpilo S, Avots A, Berberich-Siebelt F, Glockner J, Fischer C, Kerstan A, Escheqjr C, Inashkina I, Hlubek F, Jankevics E, Brabletz T, Serfling E: Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes. J Immunol 1999, 162:7294-7301
32. Hagen G, Muller S, Beato M, Suske G: Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 1994, 13:3843-3851
33. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW, Molloy PL, Paul CL: A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci USA 1992, 89:1827-1831
34. Fink K, Brink A, Vienken J, Heidland A, Stopper H: Homocysteine exerts genotoxic and antioxidative effects in vitro. Toxicol In Vitro 2007, 21:1402-1408
35. Kadonaga JT, Tjian R: Affinity purification of sequence-specific DNA binding proteins. Proc Natl Acad Sci USA 1986, 83:5889-5893
36. Soutoglou E, Talianidis I: Coordination of PIC assembly and chromatin remodeling during differentiation-induced gene activation. Science 2002, 295:1901-1904
37. Esteller M: CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene 2002, 21:5427-5440
38. Ushmorov A, Ritz O, Hummel M, Leithauser F, Moller P, Stein H, Wirth T: Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression. Blood 2004, 104:3326-3334
39. Yuan Y, Mendez R, Sahin A, Dai JL: Hypermethylation leads to silencing of the SYK gene in human breast cancer. Cancer Res 2001, 61:5558-5561
40. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H: Sp1 elements protect a CpG island from de novo methylation. Nature 1994, 371:435-438
41. Macleod D, Charlton J, Mullins J, Bird AP: Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 1994, 8:2282-2292
42. Höller M, Westin G, Jiricny J, Schaffner W: Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 1988, 2:1127-1135
43. Lachner M, Sengupta R, Schotta G, Jenuwein T: Trilogies of histone lysine methylation as epigenetic landmarks of the eukaryotic genome. Cold Spring Harb Symp Quant Biol 2004, 69:209-218
44. Jenuwein T, Allis CD: Translating the histone code. Science 2001, 293:1074-1080
45. Schotta G, Lachner M, Peters AH, Jenuwein T: The indexing potential of histone lysine methylation. Novartis Found Symp 2004, 259:22-37; discussion 37-47, 163-169
46. Schotta G, Lachner M, Sarma K, Ebert A, Sengupta R, Reuter G, Reinberg D, Jenuwein T: A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. Genes Dev 2004, 18:1251-1262
47. Esteller M, Fraga MF, Guo M, Garcia-Foncillas J, Hedenfalk I, Godwin AK, Trojan J, Vaurs-Barriere C, Bignon YJ, Ramus S, Benitez J, Caldes T, Akiyama Y, Yuasa Y, Launonen V, Canal MJ, Rodriguez R, Capella G, Peinado MA, Borg A, Aaltonen LA, Ponder BA, Baylin SB, Herman JG: DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis. Hum Mol Genet 2001, 10:3001-3007
48. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000, 92:564-569
49. Collins N, Wooster R, Stratton MR: Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers. Br J Cancer 1997, 76:1150-1156
50. Esteller M, Catasus L, Matias-Guiu X, Mutter GL, Prat J, Baylin SB, Herman JG: hMLH1 promoter hypermethylation is an early event in human endometrial tumorigenesis. Am J Pathol 1999, 155:1767-1772
51. Robertson KD, Uzvolgyi E, Liang G, Talmadge C, Sumegi J, Gonzales FA, Jones PA: The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res 1999, 27:2291-2298
52. Mizuno S, Chijiwa T, Okamura T, Akashi K, Fukumaki Y, Niho Y, Sasaki H: Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia. Blood 2001, 97:1172-1179
53. Serfling E, Berberich-Siebelt F, Avots A: NFAT in lymphocytes: a factor for all events? Sci STKE 2007, 2007:pe42
54. Kondo E, Harashima A, Takabatake T, Takahashi H, Matsuo Y, Yoshino T, Orita K, Akagi T: NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor. Eur J Immunol 2003, 33:1-11
55. Macián F, Lopez-Rodriguez C, Rao A: Partners in transcription: nFAT and AP-1. Oncogene 2001, 20:2476-2489